"The alveolar epithelium in lung injury and repair"
“肺损伤和修复中的肺泡上皮”
基本信息
- 批准号:7841316
- 负责人:
- 金额:$ 28.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAffectAlveolarAlveolitisAnimal ExperimentsApoptosisApoptoticBindingCD95 AntigensChronicCritical IllnessDataDevelopmentEpithelialEpithelial CellsEpitheliumFibrosisFunctional disorderGenesGoalsHumanIL8 geneIn VitroIncidenceInflammationInflammatoryInhibition of ApoptosisLeadLigandsLigationLinkLungMembraneModelingMorbidity - disease rateMusOryctolagus cuniculusOutcomePathogenesisPathway interactionsPatientsPlayPrincipal InvestigatorPublishingReportingRespiratory FailureRiskRoleSystemTNFRSF6 geneTNFSF6 geneTestingTherapeuticTissuesTransgenic MiceTumor Necrosis Factor Ligand Superfamily Member 6Workalveolar epitheliumcytokinedimerimprovedin vivoinjuredinjury and repairlung injurymonomermortalitynovelpublic health relevancerepairedresponsevolunteer
项目摘要
DESCRIPTION (provided by applicant): Acute lung injury (ALI) affects more than 200,000 patients in the U.S. each year and is an important cause of morbidity and mortality in hospitalized patients. Our work has shown that Fas-dependent pathways are active in the lungs of patients with ALI, and that stimulation of Fas-dependent pathways causes epithelial apoptosis and inflammation in the lungs of rabbits and mice. Published data and our preliminary studies show that chronic stimulation of Fas-dependent pathways leads to lung fibrosis. The major goal of this proposal is to determine the mechanisms linking activation of the Fas/FasL system in the lungs with the development of lung injury. The main hypothesis is that the Fas/FasL system plays an essential role in the pathogenesis of acute lung injury in mice, by a mechanism involving both apoptosis of alveolar epithelial cells, and activation of an apoptosis-independent transcriptional response in the alveolar epithelium. This hypothesis will be tested with the following specific aims: Aim 1: Determine the importance of apoptosis of alveolar epithelial cells in the development of acute lung injury in vivo. Aim 2: Determine how inhibition of apoptosis alters the transcriptional response to Fas activation in primary alveolar epithelial cells. Aim 3: Determine the factors that modulate the bioactivity of soluble Fas ligand in the lungs. Experimental approach: Murine models of lung injury and culture of lung epithelial cells will be used to address the specific aims, taking advantage of transgenic mice with specific gene deficiencies. Importance of the Results. The results of these studies will fill important gaps in our understanding of the link between epithelial apoptosis and fibrosis in the lungs of patients with acute lung injury, and could lead to novel new treatments to reduce pulmonary dysfunction and improve outcome for critically ill patients. Relevance for public Health: This study will help us understand the mechanisms that result in respiratory failure in patients who are critically ill. In addition, we will investigate the potential treatments that will facilitate the repair of injured lungs.
描述(由申请人提供):急性肺损伤(ALI)每年影响美国超过200,000例患者,是住院患者发病率和死亡率的重要原因。我们的工作表明,Fas依赖性途径在ALI患者的肺中是活跃的,并且Fas依赖性途径的刺激导致兔和小鼠肺中的上皮细胞凋亡和炎症。已发表的数据和我们的初步研究表明,Fas依赖性通路的慢性刺激导致肺纤维化。该提案的主要目标是确定连接肺中Fas/FasL系统的激活与肺损伤的发展的机制。主要假设是Fas/FasL系统在小鼠急性肺损伤的发病机制中起重要作用,其机制涉及肺泡上皮细胞的凋亡和肺泡上皮细胞中的非凋亡依赖性转录应答的激活。这一假设将与以下具体目标进行测试:目的1:确定肺泡上皮细胞凋亡在体内急性肺损伤的发展中的重要性。目的2:确定细胞凋亡的抑制如何改变原代肺泡上皮细胞Fas激活的转录反应。目的3:探讨肺组织可溶性Fas配体活性的调节因素。实验方法:肺损伤的小鼠模型和肺上皮细胞的培养将用于解决特定的目标,利用具有特定基因缺陷的转基因小鼠。结果的重要性。这些研究的结果将填补我们对急性肺损伤患者肺部上皮细胞凋亡和纤维化之间联系的理解的重要空白,并可能导致新的治疗方法,以减少肺功能障碍并改善危重患者的预后。与公共卫生的相关性:这项研究将帮助我们了解导致危重患者呼吸衰竭的机制。此外,我们将研究有助于修复受损肺部的潜在治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUSTAVO MATUTE-BELLO其他文献
GUSTAVO MATUTE-BELLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUSTAVO MATUTE-BELLO', 18)}}的其他基金
Inhibition of the Fas/FasL system in experimental acute lung injury
实验性急性肺损伤中 Fas/FasL 系统的抑制
- 批准号:
10020886 - 财政年份:2016
- 资助金额:
$ 28.41万 - 项目类别:
Acute Lung Injury: Link Between Apoptosis and Fibrosis
急性肺损伤:细胞凋亡与纤维化之间的联系
- 批准号:
7858112 - 财政年份:2007
- 资助金额:
$ 28.41万 - 项目类别:
The alveolar epithelium in lung injury and repair
肺泡上皮在肺损伤和修复中的作用
- 批准号:
7145363 - 财政年份:2006
- 资助金额:
$ 28.41万 - 项目类别:
"The alveolar epithelium in lung injury and repair"
“肺损伤和修复中的肺泡上皮”
- 批准号:
7868026 - 财政年份:2006
- 资助金额:
$ 28.41万 - 项目类别:
"The alveolar epithelium in lung injury and repair"
“肺损伤和修复中的肺泡上皮”
- 批准号:
7257227 - 财政年份:2006
- 资助金额:
$ 28.41万 - 项目类别:
"The alveolar epithelium in lung injury and repair"
“肺损伤和修复中的肺泡上皮”
- 批准号:
7440269 - 财政年份:2006
- 资助金额:
$ 28.41万 - 项目类别:
"The alveolar epithelium in lung injury and repair"
“肺损伤和修复中的肺泡上皮”
- 批准号:
7637445 - 财政年份:2006
- 资助金额:
$ 28.41万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 28.41万 - 项目类别:
Fellowship